Many people think arthritis only affects older people, or that it is merely a word for aches and pains.

At CAPA, we work to clear up these misconceptions to create a better Canada for people living with arthritis and their support groups.

Arthritis is a collection of debilitating diseases which affect Canadians of all ages and backgrounds. By collecting and producing patient resources, policy papers, and outreach projects, CAPA seeks to educate and empower people living with arthritis so they can continue to positively contribute to society and improve their health care experiences.

Our Mission

Improve access to medications, health care professionals, and services.

Increase patient involvement in arthritis research and policy agendas.

Understand and influence  research and treatments.

Meet the  CAPA Team

To learn more about the current and former members of the CAPA Board Members, click here >

Our Strategy & Funding

Thank You to our Supporters

Sources of grants and support received by CAPA in the last year include: AbbVie Canada, Amgen Canada, Arthritis Alliance of Canada, The Arthritis Society, Canadian Rheumatology Association, Eli Lilly Canada, Hoffman-La Roche, Janssen Canada, Novartis, Ontario Rheumatology Association, Pfizer Canada, and UCB Pharma.

Additionally, CAPA has also received support in the past from: Canadian Institutes for Health Research, Hoffman-La Roche, Pfizer Canada, Rx&D, Schering Canada, Scleroderma Society, and STA Communications.

When you live with arthritis,
information is your most important tool.

The Canadian Arthritis Patient Alliance (CAPA) works with various groups in the arthiritis community to ensure the voice of people living with arthritis is heard and to bring you up-to-date information on issues that affect the arthritis community. We work with healthcare professionals, health organizations, clinicians, industry, health charities, researchers, and various levels of government.

We keep Canadian people living with arthritis and their support groups understand more about their disease and have a voice in managing it.